Hepatitis B Surface Antigen Kinetics After Tenofovir Withdrawal in Chronic Hepatitis B

  • Cheng Er Hsu
  • , Yun Fan Liaw*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Letter peer-review

Original languageEnglish
Pages (from-to)389-390
Number of pages2
JournalAmerican Journal of Gastroenterology
Volume119
Issue number2
DOIs
StatePublished - 01 02 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Humans
  • Tenofovir/therapeutic use
  • Hepatitis B, Chronic/drug therapy
  • Hepatitis B Surface Antigens
  • Antiviral Agents/therapeutic use
  • Hepatitis B virus
  • DNA, Viral
  • Treatment Outcome
  • Hepatitis B e Antigens
  • Viral Load

Cite this